nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Decitabine—Gemcitabine—urinary bladder cancer	0.827	1	CrCrCtD
Entecavir—Cladribine—RRM2—urinary bladder cancer	0.00402	1	CrCbGaD
Entecavir—Transaminases increased—Doxorubicin—urinary bladder cancer	0.001	0.00596	CcSEcCtD
Entecavir—Nausea—Valrubicin—urinary bladder cancer	0.001	0.00595	CcSEcCtD
Entecavir—Fatigue—Mitomycin—urinary bladder cancer	0.001	0.00595	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—urinary bladder cancer	0.000993	0.0059	CcSEcCtD
Entecavir—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.000964	0.00572	CcSEcCtD
Entecavir—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.000938	0.00557	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—urinary bladder cancer	0.000933	0.00554	CcSEcCtD
Entecavir—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.000928	0.00551	CcSEcCtD
Entecavir—Body temperature increased—Mitomycin—urinary bladder cancer	0.00092	0.00546	CcSEcCtD
Entecavir—Renal failure—Thiotepa—urinary bladder cancer	0.000902	0.00535	CcSEcCtD
Entecavir—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.000883	0.00524	CcSEcCtD
Entecavir—Haematuria—Thiotepa—urinary bladder cancer	0.000875	0.00519	CcSEcCtD
Entecavir—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.000874	0.00519	CcSEcCtD
Entecavir—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.000867	0.00515	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—urinary bladder cancer	0.000863	0.00512	CcSEcCtD
Entecavir—Asthenia—Mitomycin—urinary bladder cancer	0.000835	0.00495	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—urinary bladder cancer	0.000815	0.00484	CcSEcCtD
Entecavir—Neutropenia—Gemcitabine—urinary bladder cancer	0.000809	0.0048	CcSEcCtD
Entecavir—Diarrhoea—Mitomycin—urinary bladder cancer	0.000796	0.00473	CcSEcCtD
Entecavir—Pancreatitis—Cisplatin—urinary bladder cancer	0.000791	0.00469	CcSEcCtD
Entecavir—Upper respiratory tract infection—Fluorouracil—urinary bladder cancer	0.000791	0.00469	CcSEcCtD
Entecavir—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000781	0.00463	CcSEcCtD
Entecavir—Dizziness—Mitomycin—urinary bladder cancer	0.000769	0.00457	CcSEcCtD
Entecavir—Renal failure—Gemcitabine—urinary bladder cancer	0.000758	0.0045	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—urinary bladder cancer	0.000754	0.00448	CcSEcCtD
Entecavir—Immune system disorder—Thiotepa—urinary bladder cancer	0.000744	0.00442	CcSEcCtD
Entecavir—Vomiting—Mitomycin—urinary bladder cancer	0.00074	0.00439	CcSEcCtD
Entecavir—Haematuria—Gemcitabine—urinary bladder cancer	0.000736	0.00437	CcSEcCtD
Entecavir—Rash—Mitomycin—urinary bladder cancer	0.000733	0.00435	CcSEcCtD
Entecavir—Dermatitis—Mitomycin—urinary bladder cancer	0.000733	0.00435	CcSEcCtD
Entecavir—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00073	0.00433	CcSEcCtD
Entecavir—Headache—Mitomycin—urinary bladder cancer	0.000729	0.00433	CcSEcCtD
Entecavir—Alopecia—Thiotepa—urinary bladder cancer	0.000728	0.00432	CcSEcCtD
Entecavir—Mental disorder—Thiotepa—urinary bladder cancer	0.000721	0.00428	CcSEcCtD
Entecavir—Malnutrition—Thiotepa—urinary bladder cancer	0.000717	0.00426	CcSEcCtD
Entecavir—Renal failure—Cisplatin—urinary bladder cancer	0.000707	0.0042	CcSEcCtD
Entecavir—Neutropenia—Etoposide—urinary bladder cancer	0.000691	0.0041	CcSEcCtD
Entecavir—Nausea—Mitomycin—urinary bladder cancer	0.000691	0.0041	CcSEcCtD
Entecavir—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.000682	0.00405	CcSEcCtD
Entecavir—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00068	0.00404	CcSEcCtD
Entecavir—Renal failure—Etoposide—urinary bladder cancer	0.000648	0.00385	CcSEcCtD
Entecavir—Leukopenia—Thiotepa—urinary bladder cancer	0.000642	0.00381	CcSEcCtD
Entecavir—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000626	0.00371	CcSEcCtD
Entecavir—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000623	0.0037	CcSEcCtD
Entecavir—Alopecia—Gemcitabine—urinary bladder cancer	0.000612	0.00363	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000606	0.0036	CcSEcCtD
Entecavir—Alopecia—Fluorouracil—urinary bladder cancer	0.000602	0.00357	CcSEcCtD
Entecavir—Immune system disorder—Cisplatin—urinary bladder cancer	0.000583	0.00346	CcSEcCtD
Entecavir—Infection—Thiotepa—urinary bladder cancer	0.000581	0.00345	CcSEcCtD
Entecavir—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000574	0.00341	CcSEcCtD
Entecavir—Alopecia—Cisplatin—urinary bladder cancer	0.000571	0.00339	CcSEcCtD
Entecavir—Hepatic failure—Methotrexate—urinary bladder cancer	0.00057	0.00338	CcSEcCtD
Entecavir—Skin disorder—Thiotepa—urinary bladder cancer	0.000568	0.00337	CcSEcCtD
Entecavir—Malnutrition—Cisplatin—urinary bladder cancer	0.000562	0.00334	CcSEcCtD
Entecavir—Leukopenia—Gemcitabine—urinary bladder cancer	0.00054	0.0032	CcSEcCtD
Entecavir—Immune system disorder—Etoposide—urinary bladder cancer	0.000534	0.00317	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—urinary bladder cancer	0.000533	0.00317	CcSEcCtD
Entecavir—Leukopenia—Fluorouracil—urinary bladder cancer	0.000531	0.00315	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000529	0.00314	CcSEcCtD
Entecavir—Alopecia—Etoposide—urinary bladder cancer	0.000523	0.0031	CcSEcCtD
Entecavir—Somnolence—Thiotepa—urinary bladder cancer	0.00052	0.00309	CcSEcCtD
Entecavir—Dyspepsia—Thiotepa—urinary bladder cancer	0.000515	0.00306	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00051	0.00303	CcSEcCtD
Entecavir—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000505	0.003	CcSEcCtD
Entecavir—Fatigue—Thiotepa—urinary bladder cancer	0.000504	0.00299	CcSEcCtD
Entecavir—Leukopenia—Cisplatin—urinary bladder cancer	0.000503	0.00299	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000495	0.00294	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000493	0.00293	CcSEcCtD
Entecavir—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000492	0.00292	CcSEcCtD
Entecavir—Infection—Gemcitabine—urinary bladder cancer	0.000489	0.0029	CcSEcCtD
Entecavir—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000484	0.00287	CcSEcCtD
Entecavir—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000483	0.00287	CcSEcCtD
Entecavir—Infection—Fluorouracil—urinary bladder cancer	0.000481	0.00285	CcSEcCtD
Entecavir—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000478	0.00284	CcSEcCtD
Entecavir—Skin disorder—Gemcitabine—urinary bladder cancer	0.000478	0.00284	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000475	0.00282	CcSEcCtD
Entecavir—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000475	0.00282	CcSEcCtD
Entecavir—Abdominal pain—Thiotepa—urinary bladder cancer	0.000462	0.00275	CcSEcCtD
Entecavir—Body temperature increased—Thiotepa—urinary bladder cancer	0.000462	0.00275	CcSEcCtD
Entecavir—Leukopenia—Etoposide—urinary bladder cancer	0.000461	0.00274	CcSEcCtD
Entecavir—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000459	0.00272	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000458	0.00272	CcSEcCtD
Entecavir—Infection—Cisplatin—urinary bladder cancer	0.000456	0.00271	CcSEcCtD
Entecavir—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00045	0.00267	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000449	0.00267	CcSEcCtD
Entecavir—Skin disorder—Cisplatin—urinary bladder cancer	0.000446	0.00265	CcSEcCtD
Entecavir—Insomnia—Gemcitabine—urinary bladder cancer	0.000445	0.00264	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000438	0.0026	CcSEcCtD
Entecavir—Insomnia—Fluorouracil—urinary bladder cancer	0.000438	0.0026	CcSEcCtD
Entecavir—Somnolence—Gemcitabine—urinary bladder cancer	0.000437	0.0026	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000435	0.00258	CcSEcCtD
Entecavir—Pancreatitis—Methotrexate—urinary bladder cancer	0.000434	0.00258	CcSEcCtD
Entecavir—Somnolence—Fluorouracil—urinary bladder cancer	0.00043	0.00255	CcSEcCtD
Entecavir—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000426	0.00253	CcSEcCtD
Entecavir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000425	0.00252	CcSEcCtD
Entecavir—Fatigue—Gemcitabine—urinary bladder cancer	0.000424	0.00252	CcSEcCtD
Entecavir—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00042	0.00249	CcSEcCtD
Entecavir—Asthenia—Thiotepa—urinary bladder cancer	0.00042	0.00249	CcSEcCtD
Entecavir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000418	0.00248	CcSEcCtD
Entecavir—Infection—Etoposide—urinary bladder cancer	0.000417	0.00248	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000415	0.00247	CcSEcCtD
Entecavir—Neutropenia—Methotrexate—urinary bladder cancer	0.000414	0.00246	CcSEcCtD
Entecavir—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000411	0.00244	CcSEcCtD
Entecavir—Skin disorder—Etoposide—urinary bladder cancer	0.000408	0.00242	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—urinary bladder cancer	0.000406	0.00241	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000405	0.0024	CcSEcCtD
Entecavir—Diarrhoea—Thiotepa—urinary bladder cancer	0.0004	0.00238	CcSEcCtD
Entecavir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000396	0.00235	CcSEcCtD
Entecavir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000389	0.00231	CcSEcCtD
Entecavir—Renal failure—Methotrexate—urinary bladder cancer	0.000388	0.0023	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—urinary bladder cancer	0.000387	0.0023	CcSEcCtD
Entecavir—Dizziness—Thiotepa—urinary bladder cancer	0.000387	0.0023	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000385	0.00229	CcSEcCtD
Entecavir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000382	0.00227	CcSEcCtD
Entecavir—Haematuria—Methotrexate—urinary bladder cancer	0.000376	0.00223	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000376	0.00223	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000374	0.00222	CcSEcCtD
Entecavir—Somnolence—Etoposide—urinary bladder cancer	0.000374	0.00222	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000373	0.00222	CcSEcCtD
Entecavir—Vomiting—Thiotepa—urinary bladder cancer	0.000372	0.00221	CcSEcCtD
Entecavir—Rash—Thiotepa—urinary bladder cancer	0.000369	0.00219	CcSEcCtD
Entecavir—Dermatitis—Thiotepa—urinary bladder cancer	0.000369	0.00219	CcSEcCtD
Entecavir—Headache—Thiotepa—urinary bladder cancer	0.000366	0.00218	CcSEcCtD
Entecavir—Renal failure—Epirubicin—urinary bladder cancer	0.000363	0.00216	CcSEcCtD
Entecavir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000363	0.00215	CcSEcCtD
Entecavir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000363	0.00215	CcSEcCtD
Entecavir—Fatigue—Etoposide—urinary bladder cancer	0.000362	0.00215	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—urinary bladder cancer	0.000358	0.00213	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000356	0.00211	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—urinary bladder cancer	0.000354	0.0021	CcSEcCtD
Entecavir—Asthenia—Gemcitabine—urinary bladder cancer	0.000353	0.0021	CcSEcCtD
Entecavir—Haematuria—Epirubicin—urinary bladder cancer	0.000352	0.00209	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000349	0.00207	CcSEcCtD
Entecavir—Nausea—Thiotepa—urinary bladder cancer	0.000347	0.00206	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000346	0.00205	CcSEcCtD
Entecavir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000344	0.00204	CcSEcCtD
Entecavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000337	0.002	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—urinary bladder cancer	0.000336	0.00199	CcSEcCtD
Entecavir—Body temperature increased—Etoposide—urinary bladder cancer	0.000332	0.00197	CcSEcCtD
Entecavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000332	0.00197	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—urinary bladder cancer	0.000332	0.00197	CcSEcCtD
Entecavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000331	0.00197	CcSEcCtD
Entecavir—Asthenia—Cisplatin—urinary bladder cancer	0.000329	0.00195	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000327	0.00194	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—urinary bladder cancer	0.000326	0.00193	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000323	0.00192	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—urinary bladder cancer	0.00032	0.0019	CcSEcCtD
Entecavir—Dizziness—Fluorouracil—urinary bladder cancer	0.00032	0.0019	CcSEcCtD
Entecavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000314	0.00186	CcSEcCtD
Entecavir—Alopecia—Methotrexate—urinary bladder cancer	0.000313	0.00186	CcSEcCtD
Entecavir—Vomiting—Gemcitabine—urinary bladder cancer	0.000313	0.00186	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—urinary bladder cancer	0.00031	0.00184	CcSEcCtD
Entecavir—Rash—Gemcitabine—urinary bladder cancer	0.00031	0.00184	CcSEcCtD
Entecavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.00031	0.00184	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—urinary bladder cancer	0.000308	0.00183	CcSEcCtD
Entecavir—Headache—Gemcitabine—urinary bladder cancer	0.000308	0.00183	CcSEcCtD
Entecavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000308	0.00183	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000307	0.00182	CcSEcCtD
Entecavir—Rash—Fluorouracil—urinary bladder cancer	0.000305	0.00181	CcSEcCtD
Entecavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000305	0.00181	CcSEcCtD
Entecavir—Headache—Fluorouracil—urinary bladder cancer	0.000303	0.0018	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000302	0.00179	CcSEcCtD
Entecavir—Asthenia—Etoposide—urinary bladder cancer	0.000301	0.00179	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000299	0.00178	CcSEcCtD
Entecavir—Alopecia—Epirubicin—urinary bladder cancer	0.000293	0.00174	CcSEcCtD
Entecavir—Nausea—Gemcitabine—urinary bladder cancer	0.000292	0.00174	CcSEcCtD
Entecavir—Vomiting—Cisplatin—urinary bladder cancer	0.000292	0.00173	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—urinary bladder cancer	0.00029	0.00172	CcSEcCtD
Entecavir—Rash—Cisplatin—urinary bladder cancer	0.000289	0.00172	CcSEcCtD
Entecavir—Dermatitis—Cisplatin—urinary bladder cancer	0.000289	0.00172	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—urinary bladder cancer	0.000289	0.00171	CcSEcCtD
Entecavir—Diarrhoea—Etoposide—urinary bladder cancer	0.000288	0.00171	CcSEcCtD
Entecavir—Nausea—Fluorouracil—urinary bladder cancer	0.000287	0.00171	CcSEcCtD
Entecavir—Dizziness—Etoposide—urinary bladder cancer	0.000278	0.00165	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000277	0.00165	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—urinary bladder cancer	0.000276	0.00164	CcSEcCtD
Entecavir—Nausea—Cisplatin—urinary bladder cancer	0.000272	0.00162	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—urinary bladder cancer	0.000271	0.00161	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000269	0.0016	CcSEcCtD
Entecavir—Vomiting—Etoposide—urinary bladder cancer	0.000267	0.00159	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000267	0.00159	CcSEcCtD
Entecavir—Rash—Etoposide—urinary bladder cancer	0.000265	0.00157	CcSEcCtD
Entecavir—Dermatitis—Etoposide—urinary bladder cancer	0.000265	0.00157	CcSEcCtD
Entecavir—Headache—Etoposide—urinary bladder cancer	0.000263	0.00156	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000261	0.00155	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—urinary bladder cancer	0.000258	0.00153	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000252	0.00149	CcSEcCtD
Entecavir—Infection—Methotrexate—urinary bladder cancer	0.00025	0.00148	CcSEcCtD
Entecavir—Nausea—Etoposide—urinary bladder cancer	0.00025	0.00148	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000247	0.00147	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000244	0.00145	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000244	0.00145	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—urinary bladder cancer	0.000239	0.00142	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000236	0.0014	CcSEcCtD
Entecavir—Infection—Epirubicin—urinary bladder cancer	0.000234	0.00139	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000231	0.00137	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—urinary bladder cancer	0.000229	0.00136	CcSEcCtD
Entecavir—Insomnia—Methotrexate—urinary bladder cancer	0.000228	0.00135	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000226	0.00134	CcSEcCtD
Entecavir—Somnolence—Methotrexate—urinary bladder cancer	0.000224	0.00133	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000222	0.00132	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000218	0.00129	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000217	0.00129	CcSEcCtD
Entecavir—Fatigue—Methotrexate—urinary bladder cancer	0.000217	0.00129	CcSEcCtD
Entecavir—Infection—Doxorubicin—urinary bladder cancer	0.000217	0.00129	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000214	0.00127	CcSEcCtD
Entecavir—Insomnia—Epirubicin—urinary bladder cancer	0.000213	0.00126	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000212	0.00126	CcSEcCtD
Entecavir—Somnolence—Epirubicin—urinary bladder cancer	0.000209	0.00124	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000207	0.00123	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000206	0.00122	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000203	0.00121	CcSEcCtD
Entecavir—Fatigue—Epirubicin—urinary bladder cancer	0.000203	0.00121	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000199	0.00118	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000199	0.00118	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—urinary bladder cancer	0.000197	0.00117	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—urinary bladder cancer	0.000194	0.00115	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000193	0.00114	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000192	0.00114	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000188	0.00112	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—urinary bladder cancer	0.000188	0.00112	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000186	0.00111	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000186	0.00111	CcSEcCtD
Entecavir—Asthenia—Methotrexate—urinary bladder cancer	0.000181	0.00107	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000178	0.00106	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000172	0.00102	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000172	0.00102	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000172	0.00102	CcSEcCtD
Entecavir—Asthenia—Epirubicin—urinary bladder cancer	0.000169	0.001	CcSEcCtD
Entecavir—Dizziness—Methotrexate—urinary bladder cancer	0.000166	0.000988	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000161	0.000957	CcSEcCtD
Entecavir—Vomiting—Methotrexate—urinary bladder cancer	0.00016	0.00095	CcSEcCtD
Entecavir—Rash—Methotrexate—urinary bladder cancer	0.000159	0.000942	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—urinary bladder cancer	0.000159	0.000941	CcSEcCtD
Entecavir—Headache—Methotrexate—urinary bladder cancer	0.000158	0.000936	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—urinary bladder cancer	0.000156	0.000928	CcSEcCtD
Entecavir—Dizziness—Epirubicin—urinary bladder cancer	0.000156	0.000925	CcSEcCtD
Entecavir—Vomiting—Epirubicin—urinary bladder cancer	0.00015	0.000889	CcSEcCtD
Entecavir—Nausea—Methotrexate—urinary bladder cancer	0.00015	0.000888	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000149	0.000885	CcSEcCtD
Entecavir—Rash—Epirubicin—urinary bladder cancer	0.000149	0.000882	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—urinary bladder cancer	0.000148	0.000881	CcSEcCtD
Entecavir—Headache—Epirubicin—urinary bladder cancer	0.000148	0.000876	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—urinary bladder cancer	0.000144	0.000856	CcSEcCtD
Entecavir—Nausea—Epirubicin—urinary bladder cancer	0.00014	0.000831	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—urinary bladder cancer	0.000139	0.000823	CcSEcCtD
Entecavir—Rash—Doxorubicin—urinary bladder cancer	0.000137	0.000816	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000137	0.000815	CcSEcCtD
Entecavir—Headache—Doxorubicin—urinary bladder cancer	0.000137	0.000811	CcSEcCtD
Entecavir—Nausea—Doxorubicin—urinary bladder cancer	0.000129	0.000769	CcSEcCtD
